Chrisy Ngilneii's Profile

B.Sc (Psychology), M.A (Sociology), Ph.D. (Epidemiology)

Chrisy Ngilneii

Chrisy is a Ph.D. Research Scholar at the University of Madras. Her area of specialization is in Epidemiology of Cancer. Writing is her passion. She has published scholarly articles on health topics in prominent journals, and had also edited two books in the academic field which are now available on Amazon.in. When she is not writing or editing, you will see her playing guitar or piano.

Written / Edited / Medically Reviewed

Belly Fat Matters for Female but Not Male Kidney Cancer Patients

Belly Fat Matters for Female but Not Male Kidney Cancer Patients

Synergy of sex differences in visceral fat measured with CT and tumor metabolism helps predict overall survival in patients with renal cell carcinoma. Belly fat affects the odds of women surviving kidney cancer but not men.

Health Watch
Mifepristone  Abortion Drug for Tumor That Causes Hearing Loss

Mifepristone Abortion Drug for Tumor That Causes Hearing Loss

Mifepristone may halt growth of human vestibular schwannoma, an intracranial tumor that causes hearing loss. Recent research suggests that it may be the most promising candidate drug for the condition.

Health Watch
Novel Treatment for Lung Cancer  Removal of Insulin Receptors

Novel Treatment for Lung Cancer Removal of Insulin Receptors

Ablation of insulin receptor substrates 1 and 2, which modulate cellular survival, growth and metabolism and is required for KRAS-driven lung cancer initiation, suppresses KRAS-driven lung tumorigenesis.

Health Watch
Eye Complication in Diabetes may Contribute to Lymphatic Neovascularization

Eye Complication in Diabetes may Contribute to Lymphatic Neovascularization

Ischemia‐ and inflammation‐induced human proliferative diabetic retinopathy microenvironment supports pathological neolymphvascularization, bringing a new concept to the proliferative diabetic retinopathy mechanisms and targeting options.

Health Watch
Detecting Lynch Syndrome Among Colorectal Cancer (CRC) Patients

Detecting Lynch Syndrome Among Colorectal Cancer (CRC) Patients

Up-front tumor sequencing in colorectal cancer is simpler and has superior sensitivity to current multitest approaches to Lynch syndrome screening, while simultaneously providing critical information for treatment selection.

Health Watch